Evidence map›Paper›PMID 27302119›Full record

ArticleThe Lancet. Neurology2016

Cannabidiol in patients with treatment-resistant epilepsy - Authors' reply.

Orrin Devinsky, Eric Marsh, Daniel Friedman

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Current application of cannabidiol (CBD) in the management and treatment of neurological disorders.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Review
  4. Towards Better Delivery of Cannabidiol (CBD).Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  5. Parasitic pharmacology: A plausible mechanism of action for cannabidiol.British journal of clinical pharmacology · 2020
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Orrin DevinskyComprehensive Epilepsy Center, New York University Langone Medical Center, New York, NY, USA. Electronic address: od4@nyu.edu.
Eric MarshDepartments of Neurology and Pediatrics, Division of Child Neurology, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Daniel FriedmanComprehensive Epilepsy Center, New York University Langone Medical Center, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabidiolEpilepsyAnticonvulsantsHumansAnticonvulsantsCannabidiol

Identifiers

PMID27302119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.